Viemed Healthcare, Inc. (VMD)
9.80
+0.21
(+2.19%)
USD |
NASDAQ |
Oct 20, 16:00
9.82
+0.02
(+0.20%)
Pre-Market: 20:00
Viemed Healthcare Research and Development Expense (TTM) : 2.456M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.456M |
| March 31, 2026 | 2.799M |
| December 31, 2025 | 3.017M |
| September 30, 2025 | 3.222M |
| June 30, 2025 | 3.204M |
| March 31, 2025 | 3.115M |
| December 31, 2024 | 3.068M |
| September 30, 2024 | 2.916M |
| June 30, 2024 | 2.752M |
| March 31, 2024 | 2.752M |
| December 31, 2023 | 2.782M |
| September 30, 2023 | 2.853M |
| June 30, 2023 | 2.93M |
| March 31, 2023 | 2.844M |
| December 31, 2022 | 2.696M |
| Date | Value |
|---|---|
| September 30, 2022 | 2.586M |
| June 30, 2022 | 2.492M |
| March 31, 2022 | 2.403M |
| December 31, 2021 | 2.11M |
| September 30, 2021 | 1.893M |
| June 30, 2021 | 1.56M |
| March 31, 2021 | 1.248M |
| December 31, 2020 | 1.083M |
| September 30, 2020 | 0.891M |
| June 30, 2020 | 0.856M |
| March 31, 2020 | 0.788M |
| December 31, 2019 | 0.848M |
| September 30, 2019 | 0.645M |
| June 30, 2019 | 0.437M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median